What it is
Mesenchymal stem cells, or MSCs, are a type of cell that researchers have studied for their ability to become several tissue types and to release signaling molecules. In labs they are collected from sources such as bone marrow, fat tissue, or umbilical cord tissue. Interest in joints comes from the hope that these cells might influence the environment inside a joint.
It is important to be clear about regulatory status. In the U.S., the only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders, used in specialist transplant settings. MSC products for joints, including those from bone marrow, adipose/SVF, umbilical cord, Wharton's jelly or other perinatal tissue, are not FDA-approved. No exosome product is FDA-approved either, and the FDA has warned the public about unapproved stem cell and exosome products.
Evidence for MSC use in joints is limited and still investigational. Research is ongoing, but results are not settled, and nothing here should be read as a claim that MSCs repair, regrow or cure anything. Calling a product 'holistic' or 'alternative' does not change its FDA status.
How it’s traditionally been approached
Joint pain and stiffness have long been approached with conservative steps, often guided by a primary care clinician, orthopedist, sports medicine physician or physical therapist. These can include activity changes, strengthening and movement work, weight and load management, and over-the-counter or prescription options.
Clinicians may also use imaging, injections that are cleared or approved for specific purposes, bracing, or assistive devices. When joints are significantly damaged, surgical options are sometimes discussed, and a surgeon can explain the benefits, risks and alternatives.
Regenerative approaches have grown alongside these methods, mostly in clinics and research settings. Because many of these offerings are unapproved, they are generally considered a conversation to have with a licensed clinician rather than a replacement for established care.
How the right provider may help
The right provider, such as an orthopedic or regenerative medicine physician or a clinical research site, may help you understand your joint concerns through a history, physical exam and, when appropriate, imaging. They may also help you sort out which options are established, which are investigational, and which are not a good fit for you.
A visit generally involves questions about your symptoms, activity and prior care. You can ask: Is this product FDA-approved for my condition? Is this part of a clinical study registered on ClinicalTrials.gov with IRB oversight? What are the risks, the alternatives, and what happens if it doesn't help?
Before moving forward, confirm the clinician's license with your state medical board and ask for written informed consent covering risks and alternatives. Watch for red flags: cure-all or 'treats everything' claims, paying to join a 'clinical trial,' testimonials offered in place of evidence, and pressure to travel abroad or across states for treatment.
The whole-person view
Body, mind and stress affect each other. Ongoing joint pain can disrupt sleep, mood and activity, and stress and worry can in turn make pain feel more intense or harder to manage. Looking at the whole person, including movement, rest, relationships and emotional well-being, can be a helpful complement to any physical evaluation.
Some people explore body-based support such as Somatic Experiences to build awareness of tension and stress held in the body, while others find talk therapy through Therapists.plus useful for coping with chronic pain and the worry that comes with health decisions. These are supportive options that sit alongside, not instead of, care from a licensed medical clinician.
Somatic Experiences: embodiment and movement →Somatic Experiences: nervous system regulation →Therapists.plus: mind body connection →
Keep in mind
- MSC products for joints are not FDA-approved in the U.S., and the FDA has warned the public about unapproved stem cell and exosome products.
- Evidence is limited and investigational, and no outcome is guaranteed; only a licensed clinician can decide what is appropriate after an evaluation.
- Verify FDA status, check ClinicalTrials.gov and IRB oversight for any study, and confirm the clinician's license with your state medical board.
- Licensed professionals should guide care for serious conditions. For emergencies call 911; in a crisis call or text 988.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
What is MSC therapy for joints?
MSC therapy for joints is the use of mesenchymal stem or stromal cells in an attempt to support a joint affected by wear, injury or inflammation. In the U.S. these uses are not FDA-approved and remain investigational. A licensed clinician can explain what is known and unknown.
Is MSC therapy for joints FDA-approved?
No, MSC therapy for joints is not FDA-approved in the U.S. The only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders. The FDA has also warned the public about unapproved stem cell products.
Does MSC therapy regrow cartilage?
There is no established evidence that MSC therapy regrows cartilage, and no clinic should promise it. Research is ongoing and the evidence is limited. Ask any provider to explain plainly what is and isn't known.
Can MSC therapy help me avoid joint surgery?
No one can promise that it will. Whether surgery or another option is appropriate depends on your individual situation, which an orthopedic clinician can evaluate. Be cautious of any claim that a treatment avoids surgery.
Are exosomes the same as MSC therapy?
No, exosomes are tiny particles released by cells, not whole cells. No exosome product is FDA-approved, and the FDA has warned about unapproved exosome products. Ask a provider about the product's regulatory status before considering it.
How can I check a provider or a clinical study?
Confirm the clinician's license through your state medical board and look up any study on ClinicalTrials.gov to see that it is registered and has IRB oversight. Ask for written informed consent covering risks and alternatives. Be wary of paying to join a 'clinical trial' or of pressure to travel for treatment.
Educational resource. StemCell.biz shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.